Catalyst Wire Dossier Catalyst Wire Dossier

Retagliptin Phosphate

retagliptin phosphate · Jiangsu HengRui Medicine Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Retagliptin Phosphate, covering 2023-07-10 to 2023-07-10. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of Retagliptin Phosphate Combined With Metformin in the Treatment of Type 2 Diabetes [Phase 3]

See pricing